The predicted impact and cost‐effectiveness of systematic testing of people with incident colorectal cancer for Lynch syndrome-Reference-Cited by-同舟云学术

The predicted impact and cost‐effectiveness of systematic testing of people with incident colorectal cancer for Lynch syndrome

Published:2019-10-08 Issue:2 Volume:212 Page:72-81
ISSN:0025-729X
Container-title:Medical Journal of Australia
language:en
Short-container-title:Medical Journal of Australia

Author:

Kang Yoon‐Jung¹^ORCID,Killen James¹,Caruana Michael¹,Simms Kate¹,Taylor Natalie¹,Frayling Ian M²³,Snowsill Tristan⁴,Huxley Nicola⁵,Coupe Veerle MH⁶,Hughes Suzanne¹,Freeman Victoria¹,Boussioutas Alex⁷⁸,Trainer Alison H⁹,Ward Robyn L¹⁰¹¹,Mitchell Gillian⁹,Macrae Finlay A⁸,Canfell Karen¹¹⁰¹¹

Affiliation:

1. Cancer Research DivisionCancer Council New South Wales Sydney NSW

2. Institute of Medical GeneticsUniversity Hospital of Wales Cardiff United Kingdom

3. Institute of Cancer and GeneticsCardiff University Cardiff United Kingdom

4. University of Exeter Medical School Exeter United Kingdom

5. Centre for Health Economics, Monash Business SchoolMonash University Melbourne VIC

6. Amsterdam Public Health Research InstituteVU University Medical Center Amsterdam The Netherlands

7. University of Melbourne Melbourne VIC

8. Royal Melbourne Hospital Melbourne VIC

9. Parkville Familial Cancer CentrePeter MacCallum Cancer Institute Melbourne VIC

10. University of Sydney Sydney NSW

11. University of New South Wales Sydney NSW

Funder

National Health and Medical Research Council

Cancer Council NSW

Publisher

AMPCo

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.5694/mja2.50356

Reference25 articles.

1. Hereditary Colorectal Cancer

2. Genetic testing for heritable mutations in the mismatch repair genes (MMR‐genes);Cancer Institute NSW;eviQ (Cancer Treatments Online)

3. Referral guidelines for colorectal cancer or polyposis risk assessment and consideration of genetic testing;Cancer Institute NSW;eviQ (Cancer Treatments Online)

4. National Institute for Health and Care Excellence.Molecular testing strategies for Lynch syndrome in people with colorectal cancer (Diagnostic guidance G27). Feb 2017.https://www.nice.org.uk/guidance/dg27(viewed July 2019).

5. Current mismatch repair deficiency tumor testing practices and capabilities: A survey of Australian pathology providers

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A registry-based study on universal screening for defective mismatch repair in colorectal cancer in Denmark highlights disparities in screening uptake and counselling referrals;Translational Oncology;2024-08

2. Mismatch repair deficiency: how reliable is the two‐antibody approach? A national real‐life study;Histopathology;2024-06-11

3. Nationwide Real-World Data of Microsatellite Instability and/or Mismatch Repair Deficiency in Cancer: Prevalence and Testing Patterns;Diagnostics;2024-05-22

4. Clinicopathological characteristics of Lynch-like syndrome;International Journal of Clinical Oncology;2024-04-20

5. A Comparison of Preferentially Expressed Antigen in Melanoma Immunohistochemistry and Diagnostic Gene Expression-Profiling Assay in Challenging Melanocytic Proliferations;The American Journal of Dermatopathology;2023-12-13